Skip to content

Effect of medicated enenma on arthritis

A CLINICO- EXPERIMENTAL STUDY ON PHARMACOKINETICS OF BASTI W.S.R. ITS ROLE IN THE MANAGEMENT OF SANDHIVATA (OSTEOARTHRITIS)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/07/002794
Enrollment
60
Registered
2012-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Osteoarthritis

Interventions

Intervention1: Group A: 3 grams of Triphala Churna three times a day after breakfast, lunch and dinner for the duration of 8 days Control Intervention1: Group B: Niruha Basti - Triphala Kwatha, Tripha

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Having sign and symptoms of Sandhivata (Osteoarthritis) as given below: a. Sandhi Shula (pain in the joint) b. Sandhi Shotha (Swelling in the joints ) c. Sandhigraha (Morning Stiffness) d. Akunchana Prasaranayoh Vedana (Pain during Flexion and extension) e. Sparsha Asahyata (Tenderness) f. Sandhisphutana (Cracking of the joints) g. Crepitus in the joint. ii) Diagnostic Findings: a. Radiologic Osteophytes (If present) iii) Chronicity less than or equal to 5 years.

Exclusion criteria

Exclusion criteria: i) Patients below 30 and above 70 years of age. ii) Cases which require surgical intervention will be excluded. iii) Patient, suffering from any chronic debilitating disease like T.B., D.M., Rheumatoid Arthritis, Gout, Varicose veins, Asthma & other chronic problems etc. and having other serious pathology. iv) Pregnant lady and lactating mother.

Design outcomes

Primary

MeasureTime frame
To assess the effect of therapy objectively, all the signs and symptoms were given scoring depending upon their severity. Complete Remission: 100% Maximum Improvement: 75% to 100% Moderate improvement: 50% to 75% Mild improvement: 25% to 50% No improvement : 0% to 25%Timepoint: To assess the effect of therapy objectively, all the signs and symptoms were given scoring depending upon their severity. Complete Remission: 100% Maximum Improvement: 75% to 100% Moderate improvement: 50% to 75% Mild improvement: 25% to 50% No improvement : 0% to 25%

Secondary

MeasureTime frame
Exacerbation in signs and synptomsTimepoint: 1 month

Countries

India

Contacts

Public ContactGyanendra Shukla

IPGT and RA, Gujarat Ayurved University

dr.gdshukla@gmail.com9374180225

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026